Lipum AB (Sweden) Performance
| LIPUM Stock | SEK 16.20 0.40 2.41% |
On a scale of 0 to 100, Lipum AB holds a performance score of 13. The company secures a Beta (Market Risk) of 0.0047, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Lipum AB's returns are expected to increase less than the market. However, during the bear market, the loss of holding Lipum AB is expected to be smaller as well. Please check Lipum AB's value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Lipum AB's current price movements will revert.
Risk-Adjusted Performance
13 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Lipum AB are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Lipum AB unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 4.4 M | |
| Free Cash Flow | -34.3 M |
Lipum |
Lipum AB Relative Risk vs. Return Landscape
If you would invest 1,170 in Lipum AB on August 31, 2024 and sell it today you would earn a total of 450.00 from holding Lipum AB or generate 38.46% return on investment over 90 days. Lipum AB is generating 0.5567% of daily returns and assumes 3.3725% volatility on return distribution over the 90 days horizon. Simply put, 30% of stocks are less volatile than Lipum, and 89% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Lipum AB Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lipum AB's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Lipum AB, and traders can use it to determine the average amount a Lipum AB's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1651
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | LIPUM | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.37 actual daily | 30 70% of assets are more volatile |
Expected Return
| 0.56 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Lipum AB is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lipum AB by adding it to a well-diversified portfolio.
Lipum AB Fundamentals Growth
Lipum Stock prices reflect investors' perceptions of the future prospects and financial health of Lipum AB, and Lipum AB fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Lipum Stock performance.
| Return On Equity | -1.81 | |||
| Return On Asset | -0.91 | |||
| Operating Margin | 117.68 % | |||
| Current Valuation | 98.1 M | |||
| Shares Outstanding | 7.65 M | |||
| Price To Book | 35.65 X | |||
| Price To Sales | 3,380 X | |||
| EBITDA | (52.11 M) | |||
| Total Debt | 1.57 M | |||
| Book Value Per Share | 0.59 X | |||
| Cash Flow From Operations | (34.3 M) | |||
| Earnings Per Share | (10.77) X | |||
| Total Asset | 49.66 M | |||
About Lipum AB Performance
Assessing Lipum AB's fundamental ratios provides investors with valuable insights into Lipum AB's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Lipum AB is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Lipum AB , a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. The company was founded in 2010 and is headquartered in Ume, Sweden. Lipum AB is traded on Stockholm Stock Exchange in Sweden.Things to note about Lipum AB performance evaluation
Checking the ongoing alerts about Lipum AB for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Lipum AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Lipum AB appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (52.26 M) with loss before overhead, payroll, taxes, and interest of (48.69 M). | |
| Lipum AB generates negative cash flow from operations | |
| About 82.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Lipum AB's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lipum AB's stock is overvalued or undervalued compared to its peers.
- Examining Lipum AB's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Lipum AB's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lipum AB's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Lipum AB's stock. These opinions can provide insight into Lipum AB's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Lipum Stock Analysis
When running Lipum AB's price analysis, check to measure Lipum AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipum AB is operating at the current time. Most of Lipum AB's value examination focuses on studying past and present price action to predict the probability of Lipum AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipum AB's price. Additionally, you may evaluate how the addition of Lipum AB to your portfolios can decrease your overall portfolio volatility.